1 Min Read
Sept 28 (Reuters) - Vistagen Therapeutics Inc:
* Vistagen receives notice of allowance from U.S. Patent and Trademark office for U.S. Patent regarding methods of production for av-101 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.